BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ortiz Zacarías NV, van Veldhoven JPD, den Hollander LS, Dogan B, Openy J, Hsiao YY, Lenselink EB, Heitman LH, IJzerman AP. Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5. J Med Chem 2019;62:11035-53. [PMID: 31742400 DOI: 10.1021/acs.jmedchem.9b00742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Huber ME, Toy L, Schmidt MF, Weikert D, Schiedel M. Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric Binding Site of GPCRs. Chemistry 2023;29:e202202565. [PMID: 36193681 DOI: 10.1002/chem.202202565] [Reference Citation Analysis]
2 . Investigation of Corrosion Inhibition Potential of Triazolopyrimidinones via Density Functional Theory and Monte-Carlo Simulations. Sci Lett 2022;10:95-105. [DOI: 10.47262/sl/10.3.132022200] [Reference Citation Analysis]
3 Teng T, Qiu S, Zhao Y, Zhao S, Sun D, Hou L, Li Y, Zhou K, Yu X, Yang C, Li Y. Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2022;23:7841. [PMID: 35887189 DOI: 10.3390/ijms23147841] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Toy L, Huber ME, Schmidt MF, Weikert D, Schiedel M. Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2. ACS Chem Biol 2022. [PMID: 35838163 DOI: 10.1021/acschembio.2c00263] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Billen M, Schols D, Verwilst P. Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists. Chem Commun (Camb) 2022;58:4132-48. [PMID: 35274633 DOI: 10.1039/d1cc07080k] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ortiz Zacarías NV, Bemelmans MP, Handel TM, de Visser KE, Heitman LH. Anticancer opportunities at every stage of chemokine function. Trends Pharmacol Sci 2021;42:912-28. [PMID: 34521537 DOI: 10.1016/j.tips.2021.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
7 Seboletswe P, Awolade P, Singh P. Recent Developments on the Synthesis and Biological Activities of Fused Pyrimidinone Derivatives. ChemMedChem 2021;16:2050-67. [PMID: 33724717 DOI: 10.1002/cmdc.202100083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ortiz Zacarías NV, Chahal KK, Šimková T, van der Horst C, Zheng Y, Inoue A, Theunissen E, Mallee L, van der Es D, Louvel J, IJzerman AP, Handel TM, Kufareva I, Heitman LH. Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2. J Med Chem 2021;64:2608-21. [PMID: 33600174 DOI: 10.1021/acs.jmedchem.0c01137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]